Vulvovaginitis in pregnant women - Revista Brasileira de Ginecologia e Obstetrícia

Home » Articles » Vulvovaginitis in pregnant women

Febrasgo Position Statement

Vulvovaginitis in pregnant women

Rev Bras Ginecol Obstet. 2024;46:e-FPS03

DOI: 10.61622/rbgo/2024FPS03

Views 226

Key points

• The balanced vaginal microbiome is the main factor defending the vaginal environment against infections. Lactobacilli play a key role in this regard, maintaining the vaginal pH within the normal range (3.8 to 4.5).

•Hormonal and immune adaptations resulting from pregnancy influence changes in the vaginal microbiome during pregnancy.

•An altered vaginal microbiome predisposes to human immunodeficiency virus (HIV) infection.

•Bacterial vaginosis is the main clinical expression of an imbalanced vaginal microbiome.

•Vulvovaginal candidiasis depends more on the host’s conditions than on the etiological agent.

•Trichomonas vaginalis is a protozoan transmitted during sexual intercourse.

•The use of probiotics is not approved for use in pregnant women.

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report
case-report -
correction
editorial
editorial -
letter
letter -
other
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Session
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Authors' Reply
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editor's Note
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Previous Note
Review Article
Short Communication
Special Article
Systematic Review
Thesis Abstract
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Comments

Your email address will not be published. Required fields are marked *

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report
case-report -
correction
editorial
editorial -
letter
letter -
other
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Session
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Authors' Reply
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editor's Note
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Previous Note
Review Article
Short Communication
Special Article
Systematic Review
Thesis Abstract
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Leia também

close-button

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Duarte G, Linhares IM, Kreitchmann R, Tristão AR, Traina E, Canti I, Takimura M, et al. Vulvovaginitis in pregnant women. Rev Bras Ginecol Obstet 2024;46:e-FPS03.

Electronic Document Format (ABNT)

Duarte, Geraldo; Linhares, Iara Moreno; Kreitchmann, Regis; Tristão, Andréa da Rocha; Traina, Evelyn; Canti, Ivete; Takimura, Marcos; Andrade, Joelma Queiroz. Vulvovaginitis in pregnant women. Rev Bras Ginecol Obstet, v. 46, e-FPS03, Apr. 2024.

Electronic Document Format (APA)

Duarte, G., Linhares, I. M., Kreitchmann, R., Tristão, A. R., Traina, E., Canti, I., Takimura, M., & Andrade, J. Q. (2024). Vulvovaginitis in pregnant women. Rev Bras Ginecol Obstet, 46, e-FPS03.

Electronic Document Format (ISO)

Duarte, Geraldo and Linhares, Iara Moreno and Kreitchmann, Regis and Tristão, Andréa da Rocha and Traina, Evelyn and Canti, Ivete and Takimura, Marcos and Andrade, Joelma Queiroz. Vulvovaginitis in pregnant women. Rev Bras Ginecol Obstet [online]. 2024, vol. 46, [cited 2024-05-13], e-FPS03. Available from: <https://journalrbgo.org/article/vulvovaginitis-in-pregnant-women/>.
✕

Vulvovaginitis in pregnant women |

Key points

• The balanced vaginal microbiome is the main factor defending the vaginal environment against infections. Lactobacilli play a key role in this regard, maintaining the vaginal pH within the normal range (3.8 to 4.5). •Hormonal and immune adaptations resulting from pregnancy influence changes in the vaginal microbiome during pregnancy. •An altered vaginal microbiome predisposes to human immunodeficiency virus (HIV) infection. •Bacterial vaginosis is the main clinical expression of an imbalanced vaginal microbiome. •Vulvovaginal candidiasis depends more on the host’s conditions than on the etiological agent. •Trichomonas vaginalis is a protozoan transmitted during sexual intercourse. •The use of probiotics is not approved for use in pregnant women.